Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,861,417
-$472,810 QoQ
Shares Held
46,394
+2.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#543
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OpenArc Corporate Advisory, LLC holds $204,562,273 across 13 Drug Manufacturers - General names. GILD ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
276,377 | $100,081,639 | |
| 2 | LLY |
ELI LILLY & Co
|
26,730 | $32,060,766 | |
| 3 | JNJ |
Johnson & Johnson
|
103,310 | $26,237,640 | |
| 4 | ABBV |
AbbVie Inc.
|
90,294 | $22,721,582 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
46,394 | $5,861,417 | |
| 6 | MRK |
Merck & Co., Inc.
|
42,950 | $5,519,075 | |
| 7 | AZN |
Astrazeneca PLC
|
27,729 | $5,257,972 | |
| 8 | NVS |
Novartis AG
|
13,228 | $2,073,092 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,861,417 | 46,394 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,334,227 | 45,449 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,458,616 | 44,473 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||